Alpha-Pyrrolidinobutiophenone

<i>alpha</i>-Pyrrolidinobutiophenone

alpha-Pyrrolidinobutiophenone

Stimulant drug

α-Pyrrolidinobutiophenone (α-PBP) is a stimulant compound developed in the 1960s[2] which has been reported as a novel designer drug. It can be thought of as the homologue lying between the two better known drugs α-PPP and α-PVP.

Quick Facts Legal status, Identifiers ...

Legality

In the United States, it is a Schedule I controlled substance.[3]

Sweden's public health agency suggested to classify α-PBP as hazardous substance on November 10, 2014.[4]

As of October 2015 α-PBP is a controlled substance in China.[5]

See also

References

  1. [1]
    "Lists of: Scheduling Actions, Controlled Substances, Regulated Chemicals" (PDF). U.S. Department of Justice, Drug Enforcement Administration, Office of Diversion Control. Archived from the original (PDF) on 17 April 2016. Retrieved 30 August 2014.
  2. [2]
    Ernst Seeger. α-Pyrrolidinyl ketones. US Patent 3314970
  3. [3]
    Schedules of Controlled Substances: Temporary Placement of 10 Synthetic Cathinones Into Schedule I
  4. [4]
    "Cannabinoider föreslås bli klassade som hälsofarlig vara". Retrieved 29 June 2015.
  5. [5]
    "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.
Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article Alpha-Pyrrolidinobutiophenone, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.